MedPath

Acarbose

Acarbose

Approved
Approval ID

6fb339f5-a3c5-4069-bd39-fc2c28e677ea

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 1, 2016

Manufacturers
FDA

Aphena Pharma Solutions - Tennessee, LLC

DUNS: 128385585

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

acarbose

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43353-951
Application NumberNDA020482
Product Classification
M
Marketing Category
C73605
G
Generic Name
acarbose
Product Specifications
Route of AdministrationORAL
Effective DateJune 13, 2014
FDA Product Classification

INGREDIENTS (5)

ACARBOSEActive
Quantity: 50 mg in 1 1
Code: T58MSI464G
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Acarbose - FDA Drug Approval Details